A Phase I/II Open Label, Multi-Center Study For The Evaluation Of Pf-3512676 (CPG 7909) [Agatolimod] In Patients With Stage Ib To Iva Cutaneous T-Cell Lymphoma

Trial Profile

A Phase I/II Open Label, Multi-Center Study For The Evaluation Of Pf-3512676 (CPG 7909) [Agatolimod] In Patients With Stage Ib To Iva Cutaneous T-Cell Lymphoma

Completed
Phase of Trial: Phase I/II

Latest Information Update: 12 Jan 2011

At a glance

  • Drugs Agatolimod (Primary)
  • Indications Mycosis fungoides
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 26 Aug 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top